Garegnani Luis, Escobar Liquitay Camila Micaela, Esteban Ignacio, Lenells Mikaela, Russo Chiara, Bruschettini Matteo, Franco Juan Va
Associate Cochrane Centre, Universidad Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Gavi, the Vaccine Alliance, 1218 Geneva, Switzerland.
Cochrane Database Syst Rev. 2025 Aug 20;8(8):CD016224. doi: 10.1002/14651858.CD016224.
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the comparative effectiveness of monoclonal antibodies (mAbs) for preventing respiratory syncytial virus (RSV) infection in children, and to evaluate the relative rankings for benefits and harms of mAbs for preventing RSV in children.
这是一项Cochrane系统评价(干预措施)的方案。目标如下:评估单克隆抗体(mAbs)预防儿童呼吸道合胞病毒(RSV)感染的相对有效性,并评估mAbs预防儿童RSV感染的获益与危害的相对排序。